CN105853704A - Medicine composition for treating tuberculosis - Google Patents

Medicine composition for treating tuberculosis Download PDF

Info

Publication number
CN105853704A
CN105853704A CN201610351542.2A CN201610351542A CN105853704A CN 105853704 A CN105853704 A CN 105853704A CN 201610351542 A CN201610351542 A CN 201610351542A CN 105853704 A CN105853704 A CN 105853704A
Authority
CN
China
Prior art keywords
parts
tuberculosis
medicine composition
pharmaceutical composition
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201610351542.2A
Other languages
Chinese (zh)
Inventor
王荔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201610351542.2A priority Critical patent/CN105853704A/en
Publication of CN105853704A publication Critical patent/CN105853704A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8967—Lilium, e.g. tiger lily or Easter lily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/13—Coniferophyta (gymnosperms)
    • A61K36/14—Cupressaceae (Cypress family), e.g. juniper or cypress
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/284—Atractylodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/32—Burseraceae (Frankincense family)
    • A61K36/324—Boswellia, e.g. frankincense
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/32—Burseraceae (Frankincense family)
    • A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/34—Campanulaceae (Bellflower family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/34—Campanulaceae (Bellflower family)
    • A61K36/342—Adenophora
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/35—Caprifoliaceae (Honeysuckle family)
    • A61K36/355—Lonicera (honeysuckle)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/62—Nymphaeaceae (Water-lily family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/68—Plantaginaceae (Plantain Family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A61K36/714—Aconitum (monkshood)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/752—Citrus, e.g. lime, orange or lemon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/78—Saururaceae (Lizard's-tail family)

Abstract

The invention discloses a medicine composition for treating tuberculosis. The medicine composition is prepared from, by weight, 8-12 parts of monkshood, 8-12 parts of myrrh, 8-12 parts of frankincense, 8-12 parts of white atractylodes rhizome, 8-10 parts of the root of straight ladybell, 5-7 parts of dried tangerine or orange peel, 8-10 parts of lily, 5-7 parts of radix asteris, 8-12 parts of plantain herb, 8-12 parts of cordate houttuynia, 8-12 parts of Cacumen biotae, 8-12 parts of raw lotus leaves and 8-12 parts of honeysuckle flowers. The medicine composition can efficiently and stably cure tuberculosis of people of all ages and both sexes, diabetes type tuberculosis, primary tuberculosis, hematogenous dissemination type tuberculosis, infiltrative pulmonary tuberculosis, chronic fibro-cavitative pulmonary tuberculosis and tuberculous pleuritis with short time.

Description

One treats phthisical pharmaceutical composition
Technical field
The present invention relates to technical field of traditional Chinese medicines, be specifically related to one and treat phthisical pharmaceutical composition.
Background technology
Pulmonary tuberculosis is the pneumonia infection disease caused by Much's bacillus, passes through respiratory infectious. Healthy People infects tulase and might not fall ill, the only just morbidity when immunity of organisms declines.Lung is tied Core is a kind of chronic infection, according to power, the difference of resistance of human body of Causative virus, in symptom Performance the most just differs, in early days: feel weak, and comparison of getting up morning is tired out, and afternoon, performance was unable, evening On the most uncontrollable excitement and cause insomnia, and become thin in the case of without other reason, time long Between cough and expectoration, slowly aggravate blood-stained sputum, expiratory dyspnea, fall asleep and WA occurs complete Body night sweat, and whole body fatigue and weakness occur.And go out after body temperature fluctuation, noon or fatigue occur Existing body temperature raises, even low-heat, and with uncomfortable in chest, the phenomenon of pectoralgia.Women without gynecological disease or There is irregular menstruation or menelipsis in the situation of person's pregnancy.When developing into osteopyrexia and fever and feverishness in palms and soles, face cheekbone Rubescent, dry cool drink, the red thready rapid pulse of tongue, even lustreless complexion, refreshing tired body is soft, coughs language micro-, Indigestion and loss of appetite loose stool, phlegm much the dilutest, anemophobia spontaneous perspiration, pale tongue with white fur have indentation, a large amount of spitting of bloods with cardiopulmonary MSOF.
The current Western medicine having a lot of pulmonary tuberculosis to cure on the market or Chinese medicine, formula has complicated and simple, Because the preparation of former medicine is different, curative effect more differs, existing Western medicine and Chinese medicine have Orally taken and externally, removal of lesions, The methods of treatments such as chemotherapy, because being limited by matrix (carrier), effect without more preferable result, and There is recurrent exerbation, it is impossible to cure the effect of normal person.
Summary of the invention
The technical problem to be solved in the present invention is the deficiency overcoming existing treatment tuberculosis drugs, it is provided that one Plant the pharmaceutical composition that treatment pulmonary tuberculosis is had better effects.
In pharmaceutical composition of the present invention, the consumption of each component is that inventor draws through a large amount of practice summaries , it is made up of the raw material of following weight parts:
Monkshood 8-12 part, myrrh 8-12 part, frankincense 8-12 part, bighead atractylodes rhizome 8-12 part, the root of straight ladybell 8-10 Part, dried orange peel 5-7 part, lily 8-10 part, aster 5-7 part, Asiatic plantain 8-12 part, cordate houttuynia 8-12 Part, cacumen biotae 8-12 part, raw lotus leaf 8-12 part, honeysuckle 8-12 part.
Preferably, it is made up of the raw material of following weight parts:
Monkshood 10 parts, myrrh 10 parts, frankincense 10 parts, the bighead atractylodes rhizome 10 parts, the root of straight ladybell 9 parts, dried orange peel 6 Part, lily 9 parts, aster 6 parts, Asiatic plantain 10 parts, cordate houttuynia 10 parts, cacumen biotae 10 parts, Raw 10 parts of lotus leaf, honeysuckle 10 parts.
The formulation of pharmaceutical composition of the present invention can be vina, capsule, granule, pill, sheet The formulation that agent, decoction etc. are medically acceptable, their preparation method, supplementary product consumption press existing routine Technique is carried out.
Present invention additionally comprises aforementioned pharmaceutical compositions application in phthisical medicine is treated in preparation.
In prescription of the present invention,
Monarch drug in a prescription:
Monkshood: dispel rheumatism, eliminating cold to stop pain, passages through which vital energy circulates is unobstructed.
Myrrh: logical stagnant blood, dissipates blood.
Frankincense: invigorate blood circulation, pain relieving, detumescence, myogenic.
The bighead atractylodes rhizome: invigorating the spleen, eliminating dampness Li Shui.
The root of straight ladybell: Yin-nourishing and body fluid promoting, clearing heat and cooling blood.
Ministerial drug:
Dried orange peel: regulate the flow of vital energy eliminating dampness and eliminating phlegm, strengthening the spleen and stomach.
Lily: clear away heart-fire relieving restlessness, antitoxic heart-soothing and sedative.
Aster: control cough with dyspnea, deficiency syndrome of the lung fire is coughed.
Asiatic plantain: diuresis, cough with lung heat, flat asthma.
Cordate houttuynia: clearing heat and detoxicating, detumescence is treated sore, is had antibacterial, antiviral, strengthens immunity.
Cacumen biotae: clearing and antitussive, cooling blood and hemostasis.
Raw lotus leaf: clearing summer-heat and damp, sending up the lucid yang, cooling blood and hemostasis.
Honeysuckle: clearing heat and detoxicating, clearing and activating the channels and collaterals.
Prescription of the present invention, to protect kidney, to protect the liver, invigorating the spleen, control lung, reaches sterilization, desinsection, dispels the wind and remove Wet, dissipate cold the most sick, passages through which vital energy circulates is unimpeded, qi and blood circulation promotion, detoxify, eliminate the phlegm, clearing heat and cooling blood, dehumidifying, dissolving phlegm Dissipating bind, promote the production of body fluid nourish blood, stop blooding, cough-relieving, insomnia, dreaminess, feel depressed, absent-minded, increase Anti-inflammatory and immunization, none example of traditional treatment process is not injury health physique and therapeutic process overflows Long.
The present invention makes up a prescription simply so that lung treatment thoroughly without leaving over calcification point, makes lung revert to nothing Normal condition before disease, each corner of each fine cell of Medicated Permeation lung, and to former for a long time Have Western medicine, dependence anti-medicine physique that Chinese medicine brings treats perfect result again.
No matter the present invention is to the pulmonary tuberculosis men and women of various age levels, fro diabetic pulmonary tuberculosis, essential Pulmonary tuberculosis, hematogenous pulmonary tuberculosis, infiltrative pulmonary tuberculosis, chronic fibro-cavitative pulmonary tuberculosis, knot Nuclearity pleurisy can efficiently, the time is short, cure smoothly.
Detailed description of the invention
With specific embodiment, the invention will be further described below, but the invention is not limited in these Embodiment.
Embodiment 1
Monkshood 80g, myrrh 120g, frankincense 80g, bighead atractylodes rhizome 120g, the root of straight ladybell 80g, dried orange peel 70g, Lily 80g, aster 70g, Asiatic plantain 80g, cordate houttuynia 120g, cacumen biotae 80g, raw lotus leaf 120g, Honeysuckle 80g.
Weigh above each raw material, boiling twice by proportional quantity, add 7 times amount water for the first time, decoct 1.5 hours, second time added 8 times amount water, decocts 1.5 hours, collecting decoction, filtered, and filtrate is dense It is reduced to the medicinal extract that relative density is 1.30 (surveying when 70 DEG C), adds appropriate cane sugar powder, routinely work Skill makes granule.
Embodiment 2
Monkshood 120g, myrrh 80g, frankincense 120g, bighead atractylodes rhizome 80g, the root of straight ladybell 100g, dried orange peel 50g, Lily 100g, aster 50g, Asiatic plantain 120g, cordate houttuynia 80g, cacumen biotae 120g, raw lotus leaf 80g, honeysuckle 120g.
Weigh above each raw material, boiling twice by proportional quantity, add 7 times amount water for the first time, decoct 1.5 hours, second time added 8 times amount water, decocts 1.5 hours, collecting decoction, filtered, and filtrate is dense It is reduced to the medicinal extract that relative density is 1.30 (surveying when 70 DEG C), adds the dextrin auxiliary material of conventional amount used, press Common process, makes capsule, 0.5g/ grain.
Embodiment 3
Monkshood 100g, myrrh 100g, frankincense 100g, bighead atractylodes rhizome 100g, the root of straight ladybell 90g, dried orange peel 60g, Lily 90g, aster 60g, Asiatic plantain 100g, cordate houttuynia 100g, cacumen biotae 100g, raw lotus leaf 100g, honeysuckle 100g.
Weigh above each raw material, after processing according to prior art, add 48 degree of soaking in Chinese liquor of 10 times amount One month, filter, obtain vina.
Experimental example: pharmaceutical composition of the present invention is to phthisical clinical efficacy
1 data and method
1.1 clinical data
Choose in January, 2009 to accept for medical treatment in December, 2011 Disease Control and Prevention Center of the city and Partial Medical Institutions 100 example Pulmonary Tuberculosis Infection patients, be randomly divided into control group and treatment group, often organize 50 examples, wherein All patients all meet the diagnosis of pulmonary tuberculosis standard that tuberculosis branch of Chinese Medical Association formulates, through iconography All find activity pathology with laboratory examination in lung, have the phlegm acid fast bacteria of 10 example patients to examine in sun Property.
In treatment group, the male sex 28 example, women 22 example, age 21-74 year, the mean age (43 ± 1.7) year, course of disease 1-8, average course of disease (5.2 ± 2.1) year；24 examples are primary pulmonary tuberculosis, 26 example secondary tuberculosis of lungs；Symptom: 17 example patients show as hemoptysis symptom, 9 examples show as weak, Becoming thin, 12 examples show as heating and night sweat, and 7 examples show as pectoralgia and breathe hard, and 6 example patients merge knot Conjunction property pleurisy；Sick position: 15 example patient's pathologies are limited to 1 lung field, and 14 example patient's pathologies are limited to two To three lung fields, 21 example patient's pathologies are limited to four to five lung fields.
In control group, the male sex 26 example, women 24 example, age 22-73 year, the mean age (42 ± 2.9) year, course of disease 1-8, average course of disease (5 ± 1.8) year；29 examples are primary pulmonary tuberculosis, 21 example secondary tuberculosis of lungs；Symptom: wherein 20 example patients show as hemoptysis symptom, 9 examples show as Weak, become thin, 5 examples show as heating and night sweat, and 7 examples show as pectoralgia and breathing hard, and 8 example patients close And associativity pleurisy；Sick position: 23 example patient's pathologies are limited to 1 lung field, 15 example patient's pathology limits In two to three lung fields, 12 example patient's pathologies are limited to four to five lung fields.
The basic document of two groups of patients, clinical symptoms and sick position scope compare, and its no statistical difference is anticipated Justice (p > 0.05), has comparativity.
1.2 methods for the treatment of
Control group use classic chemotherapy Regimen Chemotherapy: wherein isoniazid: 0.3g/d, pyrazinamide: 1.5g/d, ethambutol: 0.75g/d, streptomysin: 0.75g/d.
Treatment group selection embodiment 3 vina, each 20mL, 3 times/day.
By above scheme, control group continued treatment 12 months was 1 course for the treatment of, treatment group continued treatment 1 Individual month was 1 course for the treatment of, the liver function of patient to be made regular check on during treatment.After 1 course for the treatment of, see Examine clinical efficacy and the recurrence rate of two groups of patients.
1.3 efficacy determination
Cure: the cough of patient, heating, spitting blood transference cure, learn through impact and check that focus disappears completely Losing or fibrillatable, calcification etc., phlegm acid fast bacteria is examined in turning negative continuously, for residual cavity, stops After medicine, phlegm bacterium need to be turned out cloudy more than 1 year continuously, pleurisy patient's hydrothorax fully absorbs；
Effective: the cough of patient, heating, spitting blood transference cure, absorb bright through imaging examination focus Aobvious, void closing or reduce more than 3 months, the inspection of phlegm acid fast bacteria is negative；
Effective: the cough of patient, heating, spitting blood transference cure, absorb bright through imaging examination focus Showing or be not changed in, the inspection of phlegm acid fast bacteria turns negative continuously；
Invalid: the symptom of patient does not has any improvement or adds attention；
Deteriorating: the phlegm bacterium sun of patient turns, pathology increases, cavity increases or new cavity occurs；
Recurrence: after 1 course for the treatment of terminates, if during check in a year phlegm bacterium turned out cloudy sun again turn or New focus is had to occur being considered as.
Total effective rate=(recovery from illness+effective+effectively)/total number of cases * 100%.
1.4 statistical analysis use spss13.0 statistics software that data are carried out statistical analysis, adopt Use x2Inspection enumeration data, with P < 0.05 for statistical significance standard.
2 results
One month terminates:
Having 25 examples to cure in treatment group, 23 examples are effective, and 1 example is effective, and total effective rate 98%, after the course for the treatment of Check in 1 year is without 1 example recurrence；
Control group has 0 example to cure, and 12 examples are effective, and 25 examples are effective, and total effective rate 74%, two groups are compared Treatment group is better than control group on total effective rate, has significant difference (P < 0.05).
After 12 months:
Control group has 26 examples to cure, and 18 examples are effective, and 5 examples are effective, total effective rate 98%, after the course for the treatment of 1 Year check is without 1 example recurrence.Two groups of comparison therapy groups and control group, do not have significant difference, after the course for the treatment of Check in 1 year is without 1 example recurrence.
The effect for the treatment of group and control group are suitable, but the treatment time for the treatment of group is far smaller than comparison Group.

Claims (3)

1. one kind treat phthisical pharmaceutical composition, it is characterised in that this pharmaceutical composition be by The raw material of following weight parts is made:
Monkshood 8-12 part, myrrh 8-12 part, frankincense 8-12 part, bighead atractylodes rhizome 8-12 part, the root of straight ladybell 8-10 Part, dried orange peel 5-7 part, lily 8-10 part, aster 5-7 part, Asiatic plantain 8-12 part, cordate houttuynia 8-12 Part, cacumen biotae 8-12 part, raw lotus leaf 8-12 part, honeysuckle 8-12 part.
One the most according to claim 1 treats phthisical pharmaceutical composition, and its feature exists In: this pharmaceutical composition is made up of the raw material of following weight parts:
Monkshood 10 parts, myrrh 10 parts, frankincense 10 parts, the bighead atractylodes rhizome 10 parts, the root of straight ladybell 9 parts, dried orange peel 6 Part, lily 9 parts, aster 6 parts, Asiatic plantain 10 parts, cordate houttuynia 10 parts, cacumen biotae 10 parts, Raw 10 parts of lotus leaf, honeysuckle 10 parts.
3. the pharmaceutical composition according to any one of claim 1-2 treats phthisical medicine in preparation Application in thing.
CN201610351542.2A 2016-05-24 2016-05-24 Medicine composition for treating tuberculosis Pending CN105853704A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610351542.2A CN105853704A (en) 2016-05-24 2016-05-24 Medicine composition for treating tuberculosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610351542.2A CN105853704A (en) 2016-05-24 2016-05-24 Medicine composition for treating tuberculosis

Publications (1)

Publication Number Publication Date
CN105853704A true CN105853704A (en) 2016-08-17

Family

ID=56635834

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610351542.2A Pending CN105853704A (en) 2016-05-24 2016-05-24 Medicine composition for treating tuberculosis

Country Status (1)

Country Link
CN (1) CN105853704A (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1112437A (en) * 1994-12-23 1995-11-29 徐衡德 Medicine for treating phthisis and its preparation
CN1879805A (en) * 2006-05-10 2006-12-20 邢丽 Chinese medicine for treating tuberculosis
CN101049484A (en) * 2007-05-14 2007-10-10 郝来勤 Strong effective Chinese traditional medicine for treating lung cancer and other various cancers
CN102631638A (en) * 2012-04-05 2012-08-15 郑其田 Medicine for treating phthisis and preparation method for medicine
CN104623484A (en) * 2013-11-06 2015-05-20 青岛食之礼中草药研究所 Traditional Chinese medicine for treating pulmonary tuberculosis

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1112437A (en) * 1994-12-23 1995-11-29 徐衡德 Medicine for treating phthisis and its preparation
CN1879805A (en) * 2006-05-10 2006-12-20 邢丽 Chinese medicine for treating tuberculosis
CN101049484A (en) * 2007-05-14 2007-10-10 郝来勤 Strong effective Chinese traditional medicine for treating lung cancer and other various cancers
CN102631638A (en) * 2012-04-05 2012-08-15 郑其田 Medicine for treating phthisis and preparation method for medicine
CN104623484A (en) * 2013-11-06 2015-05-20 青岛食之礼中草药研究所 Traditional Chinese medicine for treating pulmonary tuberculosis

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
于桂艳: "中西医结合治疗老年肺结核疗效观察", 《中国当代医药》 *

Similar Documents

Publication Publication Date Title
CN102940832B (en) Medicament for treating chronic bronchitis and preparation method thereof
CN104367796B (en) A kind of Chinese medicine composition for treating canker sore
CN104474104B (en) A kind of Chinese medicine composition for preventing and treating infectious coryza of chicken and preparation method thereof
CN103432265B (en) A kind of Chinese medicinal composition preparation treating fever of children and preparation method thereof
CN101317965B (en) Traditional Chinese medicinal preparation for treating cancer
CN116139237A (en) A Chinese medicinal composition for preventing and treating respiratory tract infection caused by coronavirus, and its application
CN104117022A (en) Traditional Chinese medicinal preparation for treating schizophrenia
CN106110124A (en) A kind of antituberculotic Chinese medicine composition
CN105853704A (en) Medicine composition for treating tuberculosis
CN105727106A (en) Medicine for treating cough
CN101933743B (en) Traditional Chinese medical health pillow
CN104258306B (en) A kind of Chinese medicine preparation for treating children&#39;s eosinophilia
CN107349336A (en) Enriching yin supports lung and treats phthisical Chinese medicine composition and preparation method thereof
CN109663020A (en) A kind of Yao medicinal composition that treating pruritus and its application
CN108126008A (en) Rosemary cordyceps sinensis ball
CN105797032A (en) Medicinal composition for treating pulmonary tuberculosis
CN102813785B (en) Preparation method of traditional Chinese medicine for treating headache-type acute glomerulonephritis
CN102784344B (en) Traditional Chinese medicine preparation for treating pulmonary tuberculosis
CN106668669A (en) Traditional Chinese medicine formula for treating cough variant asthma
CN105963451A (en) Traditional Chinese medicine composition for treating pulmonary tuberculosis
CN104758346A (en) Medicine for treating migraine, as well as preparation method and preparation of medicine
CN104623465A (en) Cooperation application of traditional Chinese medicine to treatment of mycobacteria infection
CN103041269B (en) A kind of Chinese medicine for the treatment of postoperative pneumonia
CN103041266B (en) Medicine for treating pediatric postoperative pneumonia
CN103041268B (en) Medicament for treating post-traumatic pneumonia

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20160817